150 related articles for article (PubMed ID: 8891902)
21. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
22. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
23. [Molecular cytogenetics of bone tumors].
Qiu J; Zhu Q; Wang L; Li Y; Huang L; Zhang M; Chen P; Tian W; Liu W; Zhang J
Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):340-3. PubMed ID: 11832051
[TBL] [Abstract][Full Text] [Related]
24. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
25. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
26. Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma.
Ikeda S; Sumii H; Akiyama K; Watanabe S; Ito S; Inoue H; Takechi H; Tanabe G; Oda T
Jpn J Cancer Res; 1989 Jan; 80(1):6-9. PubMed ID: 2496060
[TBL] [Abstract][Full Text] [Related]
27. Comparable oncogene and tumor suppressor gene alterations in rat and human osteosarcomas.
Isfort RJ; Cody DB; Lovell G; Doersen CJ
Prog Clin Biol Res; 1992; 376():321-30. PubMed ID: 1528926
[No Abstract] [Full Text] [Related]
28. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma].
Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA
Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178
[TBL] [Abstract][Full Text] [Related]
29. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.
Ueda Y; Dockhorn-Dworniczak B; Blasius S; Mellin W; Wuisman P; Böcker W; Roessner A
J Cancer Res Clin Oncol; 1993; 119(3):172-8. PubMed ID: 8418091
[TBL] [Abstract][Full Text] [Related]
30. Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation.
Oda Y; Sakamoto A; Saito T; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Histopathology; 2001 Dec; 39(6):629-37. PubMed ID: 11903582
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
32. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
33. Integration of SV40 in human osteosarcoma DNA.
Mendoza SM; Konishi T; Miller CW
Oncogene; 1998 Nov; 17(19):2457-62. PubMed ID: 9824156
[TBL] [Abstract][Full Text] [Related]
34. Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors.
Sauceda R; Ocadiz R; Gutierrez AL; Salcedo M; Ortega V; Figueroa HH; Gariglio P
Brain Res; 1988 Apr; 427(2):123-32. PubMed ID: 2838125
[TBL] [Abstract][Full Text] [Related]
35. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene.
Qin G; Meng Z
Inhal Toxicol; 2010 Mar; 22(4):322-9. PubMed ID: 20064080
[TBL] [Abstract][Full Text] [Related]
36. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
37. [Genetic instability in osteoblastic tumors of the skeletal system].
Roessner A; Radig K; Schneider-Stock R; Mittler U; Neumann HW
Verh Dtsch Ges Pathol; 1998; 82():133-43. PubMed ID: 10095425
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
39. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
40. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]